TuHURA BIOSCIENCES, INC./NV Fair Value Adjustment of Warrants
TuHURA BIOSCIENCES, INC./NV (HURA) reported Fair Value Adjustment of Warrants of $925.27 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2020-09-18.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2020-09-18
- TuHURA BIOSCIENCES, INC./NV fair value adjustment of warrants for the quarter ending 2019-06-30 was $926.12K.
- TuHURA BIOSCIENCES, INC./NV fair value adjustment of warrants for the quarter ending 2019-03-31 was $189.00.
- TuHURA BIOSCIENCES, INC./NV fair value adjustment of warrants for the quarter ending 2018-12-31 was -$1.26K, a 241.84% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV fair value adjustment of warrants for the quarter ending 2018-09-30 was $220.00.
- TuHURA BIOSCIENCES, INC./NV fair value adjustment of warrants for fiscal 2019 was $925.27K.
- TuHURA BIOSCIENCES, INC./NV fair value adjustment of warrants for fiscal 2016 was $1.96M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2019-06-30 | $926.12K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | $926.31K derived: sum of 2 quarters · filed 2020-09-18 | $925.05K derived: sum of 3 quarters · filed 2020-09-18 | $925.27K 10-K · filed 2020-09-18 |
| 2019-03-31 | $189.00 10-Q · filed 2020-05-13 | -$1.07K derived: sum of 2 quarters · filed 2020-05-13 | -$852.00 10-Q · filed 2020-05-13 | -$3.12K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | -$1.26K 10-Q · filed 2020-02-13 | -$1.04K 10-Q · filed 2020-02-13 | -$3.31K derived: sum of 3 quarters · filed 2020-02-13 | -$5.47K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-09-30 | $220.00 10-Q · filed 2019-11-13 | -$2.05K derived: sum of 2 quarters · filed 2019-11-13 | -$4.21K derived: sum of 3 quarters · filed 2019-11-13 | -$3.32K derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | -$2.27K derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03 | -$4.43K derived: sum of 2 quarters · filed 2019-06-03 | -$3.54K derived: sum of 3 quarters · filed 2019-06-03 | -$60.11K 8-K · filed 2019-06-03 |
| 2018-03-31 | -$2.16K 10-Q · filed 2019-05-14 | -$1.27K derived: sum of 2 quarters · filed 2019-05-14 | -$57.84K 10-Q · filed 2019-05-14 | -$245.30K derived: sum of 4 quarters · filed 2019-06-03 |
| 2017-12-31 | $889.00 10-Q · filed 2019-02-11 | -$55.68K 10-Q · filed 2019-02-11 | -$243.14K derived: sum of 3 quarters · filed 2019-06-03 | -$165.66K derived: sum of 4 quarters · filed 2019-06-03 |
| 2017-09-30 | -$56.57K 10-Q · filed 2018-11-13 | -$244.03K derived: sum of 2 quarters · filed 2019-06-03 | -$166.55K derived: sum of 3 quarters · filed 2019-06-03 | |
| 2017-06-30 | -$187.46K derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03 | -$109.98K derived: sum of 2 quarters · filed 2019-06-03 | -$331.06K 8-K · filed 2019-06-03 | |
| 2017-03-31 | $77.48K 10-Q · filed 2018-05-15 | -$143.59K 10-Q · filed 2018-05-15 | ||
| 2016-06-30 | $1.96M 10-K · filed 2017-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |